world-economy

US Launches Tariff Investigation Into German Pharmaceutical Pricing

The United States has initiated a Section 301 investigation targeting Germany, citing what officials describe as systematic underpricing of innovative pharmaceutical products. The probe sets the stage for potential retaliatory tariffs on German goods, marking an escalation in trade tensions between the two nations.

The investigation comes as Germany faces mounting economic headwinds. These include softening demand from China and growing protectionist measures from Washington. German policymakers have offered limited policy alternatives to address the country's export-dependent economic model amid these external pressures.

Officials have not announced a timeline for concluding the investigation.